Boussard & Gavaudan Investment Management LLP Lantheus Holdings, Inc. Transaction History

Boussard & Gavaudan Investment Management LLP

$639 Million
Q4 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 13, 2023	BUY	$60.27 - $90.75 $571,359 - $860,310	9,480 New	9,480 $658,000

Others Institutions Holding LNTH

# of Institutions

545

Shares Held

70M

Call Options Held

673K

Put Options Held

454K

Black Rock Inc. New York, NY

8.6M
Shares

$705 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

7.24M
Shares

$594 Million
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

5.32M
Shares

$436 Million
2.53% of portfolio
Janus Henderson Group PLC London, X0

3.59M
Shares

$294 Million
0.21% of portfolio
State Street Corp Boston, MA

2.64M
Shares

$216 Million
0.01% of portfolio

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boussard & Gavaudan Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Boussard & Gavaudan Investment Management LLP with notifications on news.

Account